Nov 30 2009

Home >> Clinical Trials News Archive >> 2009 >> Nov 30 2009

Dr. Ornit Yanai-Kohelet, CEO and founder of Q-Trials, was elected to the steering committee of the Israeli Association for the advencment of the Biomedical Research Community during its foundation conference that took place in October 28th

Visit Q-Trials at the ILSI-Biomed 2010 Conference to be held June 14-16, 2010 in Tel-Aviv.

Israel has signed a research and development agreement with the state of Wisconsin to advance cooperation in the fields of water research, agriculture and human sciences.

Israel's Ministry of Finance and the Ministry of Industry, Trade and Labor today issued a tender for the establishment and management of investment funds in the field of the life sciences, with an emphasis on investment in bio-pharmacology .

American-Israeli company closes in on ALS treatment. BrainStorm Cell Therapeutics last month announced that bone marrow stem cells taken from ALS patients were capable of differentiating into nerve-supporting cells and that it had successfully tested patients' cells to confirm they could indeed undergo its differentiation procedure.